UPDATE 2-US FDA approves Pfizer's high profile breast cancer drug

UPDATE 2-US FDA approves Pfizer's high profile breast cancer drug

(Adds Pfizer, UCLA comment, background on drug). By Ransdell Pierson. Feb 3 (Reuters) – The U.S. Food and Drug Administration on Tuesday approved Pfizer Inc's Ibrance, a potential new standard of care for advanced breast cancer, in a regulatory …

4
Like
Save

Comments

Write a comment

*